drug: dexmedetomidine |
|
|
| Clinical class | sedative-hypnotic |
| Action | alpha2 adrenergic agonist |
| Chemical class | imidazole |
| CSA schedule | none |
| DEA number | none |
| Routes of administration | parenteral |
| Associated with (substance-related)
|
disorders: none |
| Availability | hospital |
U.S. Preparations:
Precedex™ (Abbott
Laboratories) FDA approved for
indication: sedation of initially intubated and mechanically ventilated
patients during treatment in an intensive care setting
U.S. Prescribing information
